Spinal Cord Stimulation (SCS) Dosing Study
Sponsor: MedtronicNeuro
Listed as NCT03284411, this PHASE4 trial focuses on Back Pain and Leg Pain and remains completed. Sponsored by MedtronicNeuro, it has been updated 18 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 13 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Apr 2020 — May 2020 [monthly]
Completed PHASE4
-
Feb 2020 — Apr 2020 [monthly]
Completed PHASE4
-
May 2019 — Feb 2020 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Mar 2019 — May 2019 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Recruiting PHASE4
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Mar 2018 — May 2018 [monthly]
Recruiting PHASE4
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE4
-
Nov 2017 — Dec 2017 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MedtronicNeuro
For direct contact, visit the study record on ClinicalTrials.gov .